Cardiovascular trials of estrogen replacement therapy

Area of Science:

• Cardiovascular Science
• Endocrinology
• Medical Research

Background:

• Estrogen therapy was widely believed to slow atherosclerosis progression.
• Favorable effects on lipids and endothelial function supported hormone replacement therapy (HRT) for cardiovascular disease prevention.
• Observational studies and animal models suggested HRT's benefits.

Purpose of the Study:

• To review findings from recent randomized clinical trials on HRT for cardiovascular disease prevention.
• To discuss the impact of these trials on the understanding of HRT's role in atherosclerosis.
• To describe ongoing clinical trials in this area.

Main Methods:

• Review of completed randomized clinical trials (e.g., Heart and Estrogen/Progestin Replacement Study, Estrogen Replacement and Atherosclerosis Trial).
• Inclusion of primary and secondary prevention cohorts.
• Examination of clinical and anatomic outcomes related to atherosclerosis.

Main Results:

• Recent randomized clinical trials have yielded surprising and controversial results.
• These findings challenge the established understanding of HRT's cardiovascular benefits.
• The efficacy of HRT for preventing coronary disease is being re-evaluated.

Conclusions:

• Contemporary understanding of HRT's role in cardiovascular disease prevention is being radically altered.
• The benefits of HRT for atherosclerosis are not as clear as previously thought.
• Further research and ongoing trials are crucial for definitive conclusions.